Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter

TelomEYE Pharmaceuticals Corporation, working on a new generation of ophthalmologic therapies, announced today the completion of a successful $1 million post-seed funding round, valuing the company at $10 million USD. The round was co-led by healthcare mogul Mehmet Ali Aydınlar,…

Sight Sciences has launched the Ergo-Series of the OMNI Surgical System in the US, which is specifically designed to help surgeons in performing minimally invasive, implant-free glaucoma procedures in adults suffering from primary open-angle glaucoma. The OMNI Surgical System facilitates…

Selagine announced a global collaboration with Grifols to develop and commercialize immunoglobulin eye drops for dry eye disease. Financial terms of the agreement were not disclosed. As per the agreement, Selagine will receive an upfront payment and annual collaboration fee,…

Dr. Seol Seung-Kwon’s research team on Smart 3D Printing at KERI, in collaboration with Professor Lim-Doo Jeong’s team at Ulsan National Institute of Science and Technology (UNIST), have jointly developed a new core technology for smart contact lenses. The lenses…

Topcon Healthcare Solutions and OphtAI, a joint venture specialized in Artificial Intelligence (AI) for ophthalmology, have announced a partnership to integrate OphtAI into Topcon’s Harmony Referral System, and provide eye care professionals with smarter access to AI services. OphtAI’s state-of-the-art…

Johnson & Johnson Vision has announced that they have received CE Mark approval for the ELITA Femtosecond Laser System. The laser is designed to perform refractive correction on patients with myopia, with or without astigmatism, using the SILK (Smooth Incision…

According to recent market research by Allied Market Research, the global vision correction market was worth $20,302.8 million in 2021, and is expected to grow at a compound annual growth rate (CAGR) of 7.4% from 2022 to 2031, reaching $41,252.7…

Frontera Therapeutics has initiated a clinical trial for its gene therapy, FT-002, which is intended for the treatment of X-linked retinitis pigmentosa (XLRP). The first patient has already been given a dose of the gene therapy product. FT-002 is Frontera’s…

Alcon Inc., a global leader in eye care, has reached a settlement agreement with J&J Surgical Vision to resolve their legal proceedings regarding femtosecond laser-assisted cataract surgery devices, including Alcon’s LenSx® device. Alcon acquired the LenSx device as part of…

Nidek has introduced the Cube α ophthalmic surgical system, which is designed to incorporate new ultrasound technology for enhanced phacoemulsification. Nidek reports that the Cube α features Gyro torsional technology within its compact design. The torsional ultrasound oscillation enhances the…